Literature DB >> 6094341

Identification of several functional subgroups of HLA-B27 by restriction of the activity of antiviral T killer lymphocytes.

A Toubert, E Gomard, F C Grumet, B Amor, J Y Muller, J P Levy.   

Abstract

Anti-Epstein-Barr virus and antiinfluenza A cytotoxic T lymphocytes (CTL) have been used to study the restriction of human antiviral responses by HLA-B27 antigens. Three functional subgroups of HLA-B27 have been clearly distinguished by this "restriction-typing assay". No cross-reaction could be detected between the three subgroups either at the CTL level or at the level of antigen-presenting cells. The cells of subgroup 1 are always positive [M2(+)] when tested in immunofluorescence with a monoclonal B27-specific antibody which divides HLA-B27 into a major M2(+) and a minor M2(-) subgroup. These M2(+) group 1 cells are apparently also HLA-B27W as previously shown by Ivanyi and co-workers using anti-HLA-CTL. Subgroup 2 includes only M2(-) cells. A comparison between this group and the previously described HLA-B27K is not fully conclusive, since two typing cells which were clearly HLA-B27K apparently did not belong to group 2. Only two donors, both of Oriental origin, have been included in subgroup 3. Both of them were "M2 intermediate". These results demonstrate (1) the existence of several functional subgroups of HLA-B27 with an interesting correlation with the M2(+), M2(-), or M2 intermediate phenotypes, and (2) the possibility of using the restriction-typing assay to define such functional subgroups not detected by classical allosera.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6094341     DOI: 10.1007/bf00364354

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  32 in total

1.  Monoclonal anti-HLA-B27 antibody (B27M1): production and lack of detectable typing difference between patients with ankylosing spondylitis, Reiter's syndrome, and normal controls.

Authors:  F C Grumet; B M Fendly; E G Engleman
Journal:  Lancet       Date:  1981-07-25       Impact factor: 79.321

2.  Recognition of HLA-A2 mutant and variant target cells by an HLA-A2 allospecific human cytotoxic T lymphocyte line.

Authors:  C F Ware; M S Krangel; D Pious; S J Burakoff; J L Strominger
Journal:  J Immunol       Date:  1983-09       Impact factor: 5.422

3.  Subtypes of HLA-B27 detected by cytotoxic T lymphocytes and their role in self-recognition.

Authors:  M H Breuning; C J Lucas; B S Breur; M Y Engelsma; G G de Lange; A J Dekker; W E Biddison; P Ivanyi
Journal:  Hum Immunol       Date:  1982-12       Impact factor: 2.850

4.  Two subgroups of HLA Bw44 defined by cell-mediated lympholysis that differ in Bw44 expression on platelets and in patterns of genetic linkage disequilibrium.

Authors:  W A Tekolf; W E Biddison; R D Aster; S Shaw
Journal:  J Immunol       Date:  1982-10       Impact factor: 5.422

5.  Virus-immune cytotoxic T cells recognize structural differences between serologically indistinguishable HLA-A2 molecules.

Authors:  W E Biddison; M S Krangel; J L Strominger; F E Ward; G M Shearer; S Shaw
Journal:  Hum Immunol       Date:  1980-10       Impact factor: 2.850

6.  Lysis of herpes simplex virus-infected targets. II. Nature of the effector cells.

Authors:  R L Hendricks; J Sugar
Journal:  Cell Immunol       Date:  1984-02       Impact factor: 4.868

7.  Specificity of anti-HLA-B27 cytotoxic T lymphocytes.

Authors:  M H Breuning; B S Breur; M Y Engelsma; B Huis; P Iványi
Journal:  Tissue Antigens       Date:  1983-10

8.  Cytotoxic T cell recognition of Epstein-Barr virus-infected B cells. I. Specificity and HLA restriction of effector cells reactivated in vitro.

Authors:  D J Moss; L E Wallace; A B Rickinson; M A Epstein
Journal:  Eur J Immunol       Date:  1981-09       Impact factor: 5.532

9.  In vitro-isolated human cytotoxic T-lymphocyte clones detect variations in serologically defined HLA antigens.

Authors:  H Spits; M Breuning; P Ivanyi; C Russo; J E de Vries
Journal:  Immunogenetics       Date:  1982       Impact factor: 2.846

10.  Differences in HLA antigen recognition by human influenza virus-immune cytotoxic T cells.

Authors:  W E Biddison; S Shaw
Journal:  J Immunol       Date:  1979-05       Impact factor: 5.422

View more
  14 in total

1.  Limiting-dilution analysis of the HLA restriction of anti-Epstein-Barr virus-specific cytolytic T lymphocytes.

Authors:  I Bourgault; A Gomez; E Gomard; J P Levy
Journal:  Clin Exp Immunol       Date:  1991-06       Impact factor: 4.330

Review 2.  Class I genes and molecules: an update.

Authors:  A M Lew; E P Lillehoj; E P Cowan; W L Maloy; M R van Schravendijk; J E Coligan
Journal:  Immunology       Date:  1986-01       Impact factor: 7.397

3.  Structural analysis of an HLA-B27 functional variant: identification of residues that contribute to the specificity of recognition by cytolytic T lymphocytes.

Authors:  M A Vega; A Ezquerra; S Rojo; P Aparicio; R Bragado; J A López de Castro
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

4.  Distribution of HLA-B27 subtypes in patients with ankylosing spondylitis: the disease is associated with a common determinant of the various B27 molecules.

Authors:  B S Breur-Vriesendorp; A J Dekker-Saeys; P Ivanyi
Journal:  Ann Rheum Dis       Date:  1987-05       Impact factor: 19.103

5.  Biology of the human histocompatibility leukocyte antigen (HLA) system and a hypothesis regarding the generation of autoimmune diseases.

Authors:  J L Strominger
Journal:  J Clin Invest       Date:  1986-05       Impact factor: 14.808

Review 6.  Acute anterior uveitis and HLA-B27.

Authors:  P J Derhaag; T E Feltkamp
Journal:  Int Ophthalmol       Date:  1990-01       Impact factor: 2.031

7.  Structural analysis of HLA-A2.4 functional variant KNE. Implications for the mapping of HLA-A2-specific T-cell epitopes.

Authors:  N Doménech; A Ezquerra; R Castaño; J A López de Castro
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

8.  Nomenclature for factors of the HLA system, 1987.

Authors: 
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

9.  Complete sequence of HLA-B27 cDNA identified through the characterization of structural markers unique to the HLA-A, -B, and -C allelic series.

Authors:  H Szöts; G Riethmüller; E Weiss; T Meo
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

10.  Six variants of HLA-B27 identified by isoelectric focusing.

Authors:  S Y Choo; P Antonelli; B Nisperos; G T Nepom; J A Hansen
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.